Seelos Therapeutics Dividend
Dividend criteria checks 0/6
Seelos Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | US$9.38 |
| Dividend yield forecast | n/a |
Recent dividend updates
No updates
Recent updates
Seelos: Data This Year Is Critical
Oct 04Seelos wins Parkinson’s research grant for gene therapy program
Aug 24Seelos: FDA Action Makes It Highly Attractive
Dec 22Seelos Therapeutics: Shares Have Finally Found A Floor But Risk Remains
Oct 01We're Hopeful That Seelos Therapeutics (NASDAQ:SEEL) Will Use Its Cash Wisely
Aug 18
Seelos: Superior Data, But Early Stage
Jun 09Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SEEL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SEEL's dividend payments have been increasing.
Dividend Yield vs Market
| Seelos Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (SEEL) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.4% |
| Industry Average (Pharmaceuticals) | 2.2% |
| Analyst forecast (SEEL) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate SEEL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SEEL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate SEEL's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SEEL has not reported any payouts.